Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1960)	9/26/2000 12:40:46 AM
From: Miljenko Zuanic	Respond to of 4974

So, they are immediately excluded as munch (AMGN) option. Go PDLI! Miljenko

To: scaram(o)uche who wrote (1960)	9/29/2000 4:29:17 PM
From: nigel bates	Read Replies (1) \| Respond to of 4974

Oh.....my......gawd!!. No sweat... FREMONT, Calif., Sept. 29 /PRNewswire/ -- Protein Design Labs, Inc. (PDL) (Nasdaq: PDLI - news) today announced the completion of a public offering by the company of 3,000,000 shares of its common stock at a price of $118.4375 per share. Gross proceeds from the offering were approximately $355.3 million. The offering was co-led by Credit Suisse First Boston and CIBC World Markets and was co-managed by SG Cowen. The underwriters have an option to purchase up to 450,000 additional shares to cover over-allotments, if any.